肝癌动脉化疗栓塞术中肝脏能量储备功能研究   

STUDY ON HEPATIC ENERGY FUNCTIONAL RESERVE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATEDBY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

作　　者：刘占举[1] 李天晓[1] 徐志林[1] 徐莉 

机构地区：[1]河南医科大学第二医院

出　　处：《中华消化杂志》1995年第6期324-326,共3页Chinese Journal of Digestion

基　　金：河南省教委基金

摘　　要：对３６例行ＴＡＥ治疗的肝癌患者，术前氧化还原耐受指数（ＲＴＩ）及术后动脉血酮体比（ＡＫＢＲ）测定来评价肝脏能量储备功能。按术后ＡＫＢＲ值分Ａ：≥０．７，Ｂ：０．４～０．７及Ｃ：＜０．４，在ＲＴＩ≥０．５的２１例中，属Ａ、Ｂ及ｃ者分别为１５、６及０例，术后１个月内无死亡；而在ＲＴＩ＜０．５的１５例中，属Ａ、Ｂ及ｃ者分别为５、８及２例，术后１个月内Ｂ有１例死亡，Ｃ中２例均死亡。由此认为术前ＲＴＩ及术后ＡＫＢＲ测定可准确判断患者肝脏能量储备功能并评价预后。n order to evaluate the hepatic energy functional reserve in patients with hepatocellularcarcinoma treated by transcatheter arterial chemoembolization(TAE),the redox toleranceindex (RTI)prior to TAE and arterial ketone body ratio (AKBR)after TAE were measured in36 cases. As a r sult, in 2l cases with RTI≥0.5 prior to the procedure and pro AKBR, therewere l5, 6 and O cases≥0.7,0.4～0.7 and <0.4 respectively, no death occurred within the firstpostoperative month; but there were 5,8 and 2 cases respectively with RTI<0.5, one withAKBR 0.4～0.7 and two with <0.4,died within one month. Our findings suggest that RTI andAKBR can be used to estimate accurately the hepatic energy functional reserve and predictthe outcome.

关 键 词：肝癌 栓塞治疗 动脉血酮体仳 肝脏能量储备 

分 类 号：R735.705[医药卫生—肿瘤]